Cardiovascular Risk Evaluation and Antiretrovirals in HIV

CompletedOBSERVATIONAL
Enrollment

1,024

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

November 30, 2006

Conditions
Cardiovascular RiskHIV Infections
Trial Locations (1)

SE30AA

Guys & ST Thomas' Foundation Hospitals, London

All Listed Sponsors
collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

lead

King's College London

OTHER

NCT01015092 - Cardiovascular Risk Evaluation and Antiretrovirals in HIV | Biotech Hunter | Biotech Hunter